Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Kelun Pharma Buys Qingfa Pharma

publication date: Dec 28, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sichuan Kelun Pharma will purchase Guangdong Qingfa Pharmaceutical for a total of 148 million RMB ($22.3 million). The price consists of 24 million RMB ($3.6 million) for the company and 124 million RMB ($18.7 million) for repayment of debt. This is small change for Kelun Pharma, which raised $750 million in its IPO on the Shenzhen exchange in May of this year. More details....

Stock Symbol: (SZEX: 002422)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners